| AMARIN CORP.ADR NEW 2025 |
| USA |
| Gesundheit |
| US0231114044 / A41557 |
| EH3 (Frankfurt) / AMRN (NASDAQ) |
| FRA:EH3, ETR:EH3, EH3:GR, NASDAQ:AMRN |
| - |
| https://www.amarincorp.co.. |
|
Amarin Corporation plc - American Depositary Receipt represents shares in Amarin Corporation plc, a pharmaceutical company focused on the commercialization and development of therapeutics for cardiovascular health in the United States, Europe, and in..
>Volltext.. |
| 247.52 Mio. EUR |
| -5.82 Mio. EUR |
| 183 Mio. EUR |
| -9.28 Mio. EUR |
| -33.28 Mio. EUR |
| -1.61 EUR |
| 5.19 Mio. EUR |
| 115.15 Mio. EUR |
| 5.76 Mio. EUR |
| 1.56 |
| -6.21% |
| 52.45% |
| - |
| - |
| - |
| - |
| AMARIN |
| 03.05.26 |
|